Navigation Links
Althea Technologies & Profectus BioSciences Sign Manufacturing Agreement For Plasmid DNA Production
Date:2/26/2013

ies, Inc.
Althea Technologies is a fully integrated, contract development and manufacturing organization located in San Diego, CA providing clinical and commercial product development services. Althea offers cGMP drug product filling in both vials and syringes, and production of microbial-derived recombinant proteins and plasmid DNA. In conjunction with these manufacturing operations, Althea offers comprehensive development services including: upstream and downstream process development, analytical development, lyophilization cycle, complex formulation, product release and ICH-compliant stability testing. Althea's formulation technology platform includes Crystalomics®, a proprietary technology that offers a formulation solution for large molecule products that must be delivered at high concentrations or as sustained release formulations. For more information, visit www.altheatech.com. 

About Profectus Biosciences.
Profectus BioSciences, Inc. is a technology based vaccine company devoted to the treatment and prevention of infectious diseases and related cancers, with the goal of reducing morbidity and mortality. Since its inception in 2003, the Company's strategic intent has been to acquire and develop the technologies needed to achieve this goal. The Company has licensed a group of vaccine?based technologies from Wyeth Vaccines (now Pfizer, Inc.) that greatly enhance the immunogenicity of prophylactic and therapeutic vaccines based on a "prime?boost" strategy. This strategy uses the delivery of a best?in?class pDNA vaccine to "prime" the immune system, followed by a first-in-class "boost" with an rVSV vector. Current disease and virus targets include hepatitis C virus (HCV), human papilloma virus (HPV), herpes simplex virus type 2 (HSV?2), human immunodeficiency virus (HIV), Ebola virus, Marburg Virus, the arenaviruses and malaria. The Profectus HIV DNA vaccine program has b
'/>"/>

SOURCE Althea Technologies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology news :

1. University of Colorado and Orphan Technologies sign agreement
2. Preclinical study shows potential of new technologies to detect response to cancer therapy earlier
3. LaserLock Technologies Files for Provisional Patent Enabling Mobile Phones with Anti-Counterfeiting Technology
4. Going negative: Stanford scientists explore new technologies that remove atmospheric CO2
5. New modeling approach transforms imaging technologies
6. Life Technologies ayudará a identificar 20.000 restos humanos encontrados en fosas comunes en Libia
7. New supercomputer coming to EMSL this summer, supplied by Atipa Technologies
8. UT Dallas researchers awarded $4.3 million to create next-generation technologies
9. ASU partners with Life Technologies on US DHHS funded project to rapidly assess radiation dose
10. Lyncean Technologies Inc. sells Compact Light Source to Munich biomedical-imaging research center
11. NREL researchers use imaging technologies to solve puzzle of plant architecture
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... proteins in the brain responsible for protecting nerve cells ... increase cell survival. , The discovery, made by researchers ... the EMBO journal with additional comment in ... stroke and other brain diseases. , The research builds ... protein, known as SUMO, responsible for controlling the chemical ...
(Date:5/17/2013)... team of scientists using a new X-ray method recorded ... frog embryo in greater detail than ever before., This ... and the search for new treatments for genetic diseases., ... Technologie in Germany, in collaboration with the Advanced Photon ... Laboratory, released the most precise depiction ever of the ...
(Date:5/16/2013)... shorelines to predict the stability of today,s largest ice sheets ... three million years ago, for example when Earth was ... evidence of a high sea level due to ice sheet ... to think that if the world,s largest ice sheets collapsed ... in our modern, progressively warming world. , However, a ...
Breaking Biology News(10 mins):SUMO wrestling cells reveal new protective mechanism target for stroke 2New X-ray method shows how frog embryos could help thwart disease 2World's biggest ice sheets likely more stable than previously believed 2
... caribou are also central to the health and vitality of ... soon become endangered ,by threats such as oil exploration and ... the Wildlife Conservation Society and the World Wildlife Fund. ... Press Toronto, $50/29.00), the book highlights the caribou in terms ...
... eastern Burma (also known as Myanmar) are widespread and ... Hopkins Bloomberg School of Public Health. The researchers report ... home delivery during their last pregnancy and displaced women ... no antenatal care. Human rights violations, like displacement and ...
... both store information and process that information. In a computer, ... information, the central processing unit (CPU) does the processing. But ... the same cells neurons leading researchers to ask ... functions. In a discovery that may one day ...
Cached Biology News:Rudolf's kin more than just Santa's ride 2Rudolf's kin more than just Santa's ride 3Maternal health problems in Myanmar widespread 2SUNY Downstate researchers find that memory storage molecule preserves complex memories 2
(Date:5/17/2013)... occurs when the transplant recipient,s immune system identifies the ... was previously thought that T cells, the immune cells ... known as chemokines in order to migrate to the ... of Clinical Investigation , Fadi Lakkis and colleagues at ... chemokine stimulation of T cells is not required for ...
(Date:5/17/2013)... The new Public-Private Partnership (PPP) in Photonics ... recent annual meeting drew praise from community leaders from ... called the action “a huge step forward … a ... innovation.” , The Board of Stakeholders voted to approve ... at its 29 April meeting in Brussels, which was ...
(Date:5/17/2013)... 17, 2013  Cellular Biomedicine Group (OTCQB: CBMG) ... of the total projected enrollment required for its ... preliminary efficacy of the medical technology haMPC (Human ... (KOA). To date the trial has had no ... Phase I open label clinical research trial for ...
(Date:5/17/2013)... , May 17, 2013  Insero Health, Inc., ... needs in epilepsy and related neurological disorders, is today ... its lead compound INS001 in patients with drug-resistant epilepsy.  ... and Device Trials (AED) Xll meeting by Dr. ... and Chairman of Insero,s Scientific Advisory Board.  In this ...
Breaking Biology Technology:SPIE Joins in Praise for ‘Huge Step Forward’ for Innovation R&D Enabled by Photonics21 Actions 2SPIE Joins in Praise for ‘Huge Step Forward’ for Innovation R&D Enabled by Photonics21 Actions 3Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis 2Insero Health Reports Positive Data on Phase I Trial of Novel Therapy for Drug-resistant Epilepsy 2
... China, Nov. 4 /Xinhua-PRNewswire-FirstCall/ -- China Sky One,Medical, ... (Nasdaq: CSKI ), a,leading fully integrated pharmaceutical ... China ("PRC"), today announced that it,will conduct a ... November 10,2008 to discuss its third quarter 2008 ...
... Period, DUBLIN, Calif., Nov. 4 SuperGen, Inc.,(Nasdaq: ... discovery and,development of novel cancer therapies, today announced financial ... 30, 2008., Total revenues for the 2008 third ... same prior year period. Total revenues for the,2008 third ...
... ANDS ) announced today that it will present ... Tuesday, November 11, 2008,at 11:35 a.m. EST (8:35 a.m. ... Worland, Ph.D., President and Chief Executive Officer of Anadys,will ... programs: ANA598,and ANA773 in hepatitis C and ANA773 in ...
Cached Biology Technology:China Sky One Medical, Inc. Announces Conference Call to Discuss Third Quarter 2008 Results 2China Sky One Medical, Inc. Announces Conference Call to Discuss Third Quarter 2008 Results 3SuperGen Reports 2008 Third Quarter Financial Results 2SuperGen Reports 2008 Third Quarter Financial Results 3SuperGen Reports 2008 Third Quarter Financial Results 4SuperGen Reports 2008 Third Quarter Financial Results 5SuperGen Reports 2008 Third Quarter Financial Results 6SuperGen Reports 2008 Third Quarter Financial Results 7SuperGen Reports 2008 Third Quarter Financial Results 8SuperGen Reports 2008 Third Quarter Financial Results 9SuperGen Reports 2008 Third Quarter Financial Results 10Anadys Pharmaceuticals to Present at Rodman & Renshaw Annual Global Investment Conference 2
... ProteomeLab PF 2D is an automated, two-dimensional ... protein mixtures. Part of Beckman Coulters ... produces results in just hours. The ... present in cell lysates, addressing a key ...
... Rapid-Screen cDNA Library Panels were designed for ... sets of PCRs to identify the desired ... performed in a 96-well "Master Plate," where ... clones. Having identified the positive well(s) by ...
... HORIBA Jobin Yvons Protein 295 ex can ... protein sample in only a few minutes. ... amino acids tyrosine and tryptophan, the Protein ... NanoLED-17, a pulsed diode emitting 295 nm. ...
... is a research grade spectrofluorometer which offers ... speeds of up to 60,000nm/min. Its ... concentrated light beam along with low sample ... FL Solutions, PC fluorescence applications software, which ...
Biology Products: